Haermonics
Eindhoven, NL · 2 known investors
Haermonics is a clinical-stage medtech company that developed the Haermonics Pure System, a continuous postoperative pericardial flush therapy designed to keep chest tubes clear and prevent bleeding-related complications after open-heart cardiac surgery. The device targets retained blood syndrome and the need for surgical re-exploration in cardiac surgery patients.
Founders & leadership
DR
David R. KoolbergeninInventor of the therapy; Congenital Cardiothoracic Surgeon
Investors · 2
Frequently asked questions
- What does Haermonics do?
- Haermonics is a clinical-stage medtech company that developed the Haermonics Pure System, a continuous postoperative pericardial flush therapy designed to keep chest tubes clear and prevent bleeding-related complications after open-heart cardiac surgery. The device targets retained blood syndrome and the need for surgical re-exploration in cardiac surgery patients.
- Who founded Haermonics?
- Haermonics was founded by David R. Koolbergen.
- Who are Haermonics's investors?
- Haermonics's investors include BOM, NLC.
- Where is Haermonics headquartered?
- Haermonics is headquartered in Eindhoven, NL.